160 related articles for article (PubMed ID: 35101425)
1. Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis.
Gomes D; Wang S; Goodspeed L; Turk KE; Wietecha T; Liu Y; Bornfeldt KE; O'Brien KD; Chait A; den Hartigh LJ
J Lipid Res; 2022 Mar; 63(3):100174. PubMed ID: 35101425
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice.
Mullick AE; Fu W; Graham MJ; Lee RG; Witchell D; Bell TA; Whipple CP; Crooke RM
J Lipid Res; 2011 May; 52(5):885-96. PubMed ID: 21343632
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
4. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
[TBL] [Abstract][Full Text] [Related]
5. Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.
Basu D; Hu Y; Huggins LA; Mullick AE; Graham MJ; Wietecha T; Barnhart S; Mogul A; Pfeiffer K; Zirlik A; Fisher EA; Bornfeldt KE; Willecke F; Goldberg IJ
Circ Res; 2018 Feb; 122(4):560-567. PubMed ID: 29321129
[TBL] [Abstract][Full Text] [Related]
6.
Arndt L; Hernandez-Resendiz I; Moos D; Dokas J; Müller S; Jeromin F; Wagner R; Ceglarek U; Heid IM; Höring M; Liebisch G; Stadler SC; Burkhardt R
Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):979-994. PubMed ID: 37078290
[TBL] [Abstract][Full Text] [Related]
7. Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.
Jarrett KE; Lee C; De Giorgi M; Hurley A; Gillard BK; Doerfler AM; Li A; Pownall HJ; Bao G; Lagor WR
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):1997-2006. PubMed ID: 30026278
[TBL] [Abstract][Full Text] [Related]
8. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.
Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1223-30. PubMed ID: 10323773
[TBL] [Abstract][Full Text] [Related]
9. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7.
Lu R; Yuan T; Wang Y; Zhang T; Yuan Y; Wu D; Zhou M; He Z; Lu Y; Chen Y; Fan J; Liang J; Cheng Y
EBioMedicine; 2018 Oct; 36():29-38. PubMed ID: 30243490
[TBL] [Abstract][Full Text] [Related]
11. High fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis-inactivated Δ6-fatty acid desaturase-deficient mouse.
Stoffel W; Binczek E; Schmidt-Soltau I; Brodesser S; Wegner I
Mol Metab; 2021 Dec; 54():101335. PubMed ID: 34530175
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
[TBL] [Abstract][Full Text] [Related]
13. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
[TBL] [Abstract][Full Text] [Related]
14. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
15. Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor.
Lede V; Franke C; Meusel A; Teupser D; Ricken A; Thiery J; Schiller J; Huster D; Schöneberg T; Schulz A
PLoS One; 2016; 11(12):e0167888. PubMed ID: 28030540
[TBL] [Abstract][Full Text] [Related]
16. SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
Gurzeler E; Ruotsalainen AK; Laine A; Valkama T; Kettunen S; Laakso M; Ylä-Herttuala S
PLoS One; 2021; 16(11):e0258408. PubMed ID: 34767557
[TBL] [Abstract][Full Text] [Related]
17. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis.
Meurs I; Lammers B; Zhao Y; Out R; Hildebrand RB; Hoekstra M; Van Berkel TJ; Van Eck M
Atherosclerosis; 2012 Mar; 221(1):41-7. PubMed ID: 22196936
[TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs.
Davis BT; Wang XJ; Rohret JA; Struzynski JT; Merricks EP; Bellinger DA; Rohret FA; Nichols TC; Rogers CS
PLoS One; 2014; 9(4):e93457. PubMed ID: 24691380
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis.
Kim S; Graham MJ; Lee RG; Yang L; Kim S; Subramanian V; Layne JD; Cai L; Temel RE; Shih D; Lusis AJ; Berliner JA; Lee S
Nutr Metab Cardiovasc Dis; 2019 Mar; 29(3):306-315. PubMed ID: 30738642
[TBL] [Abstract][Full Text] [Related]
20. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
Park JG; Xu X; Cho S; Lee AH
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
